Patent Number: 6,254,875

Title: Methods for use of OMP26 from Haemophilus influenzae

Abstract: A novel antigenic protein derived from the outer membrane of H. influenzae is provided. DNA sequences encoding such a protein are also provided as are vaccines comprising the protein and methods of immunizing a subject against H. influenzae infection. The invention also includes methods for the prophylaxis or treatment of respiratory tract infections or otitis media, as well as methods for the detection of H. influenzae, and kits for use in such methods.

Inventors: Kyd; Jennelle (McKeller, AU), Cripps; Allan (Curtin, AU), Smith; Christopher John (Dembighshire, GB)

Assignee: Provalis UK Limited

International Classification: C07K 14/195 (20060101); C07K 14/285 (20060101); A61K 39/00 (20060101); A61K 039/102 ()

Expiration Date: 07/03/2018